Characterization of large genomic deletions in the FBN1 gene using multiplex ligation-dependent probe amplification

Larissa V. Furtado, Whitney Wooderchak-Donahue, Alan F. Rope, Angela T. Yetman, Tracey Lewis, Parker Plant, Pinar Bayrak-Toydemir

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Connective tissue diseases characterized by aortic aneurysm, such as Marfan syndrome, Loeys-Dietz syndrome and Ehlers Danlos syndrome type IV are heterogeneous and despite overlapping phenotypes, the natural history, clinical manifestations and interventional course for each diagnosis can be quite unique. The majority of mutations involved in the etiology of these disorders are missense and nonsense mutations. However, large deletions and duplications undetected by sequencing may be implicated in their pathogenesis, and may explain the apparent lack of genotype-phenotype correlation in a subset of patients. The objective of this study was to search for large pathogenic deletions and/or duplications in the FBN1, TGFβR1, and TGFβR2 genes using multiplex-ligation dependent probe amplification (MLPA) in patients with aortopathy, in whom no mutations in the FBN1, TGFβR1, and TGFβR2 genes were identified by sequencing.Methods: The study included 14 patients from 11 unrelated families with aortic aneurysm. Of those, six patients (including 3 first-degree relatives), fulfilled the revised Ghent criteria for Marfan syndrome, and eight had predominantly aortic aneurysm/dilatation with variable skeletal and craniofacial involvement. MLPA for FBN1, TGFβR1, and TGFβR2 was carried out in all patients. A 385 K chromosome 15 specific array was used in two patients with a deletion of the entire FBN1 in order to define its size and boundaries.Results: We identified two novel large deletions in the FBN1 gene in four patients of two unrelated families who met clinical diagnostic criteria for Marfan syndrome. One patient was found to have a FBN1 deletion encompassing exons 1-5. The other three patients had a 542 Kb deletion spanning the whole FBN1 gene and five additional genes (SLC24A5, MYEF2, CTXN2, SLC12A1, DUT) in the chromosome 15.Conclusions: Our findings expand the number of large FBN1 deletions, and emphasize the importance of screening for large genomic deletions in connective tissue disorders featuring aortopathies, especially for those with classic Marfan phenotype.

Original languageEnglish (US)
Article number119
JournalBMC Medical Genetics
Volume12
DOIs
StatePublished - Sep 21 2011

Fingerprint

Multiplex Polymerase Chain Reaction
Genes
Marfan Syndrome
Aortic Aneurysm
Chromosomes, Human, Pair 15
Loeys-Dietz Syndrome
Ehlers-Danlos Syndrome
Phenotype
Mutation
Connective Tissue Diseases
Nonsense Codon
Genetic Association Studies
Missense Mutation
Natural History
Connective Tissue
Dilatation
Exons

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Characterization of large genomic deletions in the FBN1 gene using multiplex ligation-dependent probe amplification. / Furtado, Larissa V.; Wooderchak-Donahue, Whitney; Rope, Alan F.; Yetman, Angela T.; Lewis, Tracey; Plant, Parker; Bayrak-Toydemir, Pinar.

In: BMC Medical Genetics, Vol. 12, 119, 21.09.2011.

Research output: Contribution to journalArticle

Furtado, Larissa V. ; Wooderchak-Donahue, Whitney ; Rope, Alan F. ; Yetman, Angela T. ; Lewis, Tracey ; Plant, Parker ; Bayrak-Toydemir, Pinar. / Characterization of large genomic deletions in the FBN1 gene using multiplex ligation-dependent probe amplification. In: BMC Medical Genetics. 2011 ; Vol. 12.
@article{165aa5debd944e14a0f038fecb01d087,
title = "Characterization of large genomic deletions in the FBN1 gene using multiplex ligation-dependent probe amplification",
abstract = "Background: Connective tissue diseases characterized by aortic aneurysm, such as Marfan syndrome, Loeys-Dietz syndrome and Ehlers Danlos syndrome type IV are heterogeneous and despite overlapping phenotypes, the natural history, clinical manifestations and interventional course for each diagnosis can be quite unique. The majority of mutations involved in the etiology of these disorders are missense and nonsense mutations. However, large deletions and duplications undetected by sequencing may be implicated in their pathogenesis, and may explain the apparent lack of genotype-phenotype correlation in a subset of patients. The objective of this study was to search for large pathogenic deletions and/or duplications in the FBN1, TGFβR1, and TGFβR2 genes using multiplex-ligation dependent probe amplification (MLPA) in patients with aortopathy, in whom no mutations in the FBN1, TGFβR1, and TGFβR2 genes were identified by sequencing.Methods: The study included 14 patients from 11 unrelated families with aortic aneurysm. Of those, six patients (including 3 first-degree relatives), fulfilled the revised Ghent criteria for Marfan syndrome, and eight had predominantly aortic aneurysm/dilatation with variable skeletal and craniofacial involvement. MLPA for FBN1, TGFβR1, and TGFβR2 was carried out in all patients. A 385 K chromosome 15 specific array was used in two patients with a deletion of the entire FBN1 in order to define its size and boundaries.Results: We identified two novel large deletions in the FBN1 gene in four patients of two unrelated families who met clinical diagnostic criteria for Marfan syndrome. One patient was found to have a FBN1 deletion encompassing exons 1-5. The other three patients had a 542 Kb deletion spanning the whole FBN1 gene and five additional genes (SLC24A5, MYEF2, CTXN2, SLC12A1, DUT) in the chromosome 15.Conclusions: Our findings expand the number of large FBN1 deletions, and emphasize the importance of screening for large genomic deletions in connective tissue disorders featuring aortopathies, especially for those with classic Marfan phenotype.",
author = "Furtado, {Larissa V.} and Whitney Wooderchak-Donahue and Rope, {Alan F.} and Yetman, {Angela T.} and Tracey Lewis and Parker Plant and Pinar Bayrak-Toydemir",
year = "2011",
month = "9",
day = "21",
doi = "10.1186/1471-2350-12-119",
language = "English (US)",
volume = "12",
journal = "BMC Medical Genetics",
issn = "1471-2350",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Characterization of large genomic deletions in the FBN1 gene using multiplex ligation-dependent probe amplification

AU - Furtado, Larissa V.

AU - Wooderchak-Donahue, Whitney

AU - Rope, Alan F.

AU - Yetman, Angela T.

AU - Lewis, Tracey

AU - Plant, Parker

AU - Bayrak-Toydemir, Pinar

PY - 2011/9/21

Y1 - 2011/9/21

N2 - Background: Connective tissue diseases characterized by aortic aneurysm, such as Marfan syndrome, Loeys-Dietz syndrome and Ehlers Danlos syndrome type IV are heterogeneous and despite overlapping phenotypes, the natural history, clinical manifestations and interventional course for each diagnosis can be quite unique. The majority of mutations involved in the etiology of these disorders are missense and nonsense mutations. However, large deletions and duplications undetected by sequencing may be implicated in their pathogenesis, and may explain the apparent lack of genotype-phenotype correlation in a subset of patients. The objective of this study was to search for large pathogenic deletions and/or duplications in the FBN1, TGFβR1, and TGFβR2 genes using multiplex-ligation dependent probe amplification (MLPA) in patients with aortopathy, in whom no mutations in the FBN1, TGFβR1, and TGFβR2 genes were identified by sequencing.Methods: The study included 14 patients from 11 unrelated families with aortic aneurysm. Of those, six patients (including 3 first-degree relatives), fulfilled the revised Ghent criteria for Marfan syndrome, and eight had predominantly aortic aneurysm/dilatation with variable skeletal and craniofacial involvement. MLPA for FBN1, TGFβR1, and TGFβR2 was carried out in all patients. A 385 K chromosome 15 specific array was used in two patients with a deletion of the entire FBN1 in order to define its size and boundaries.Results: We identified two novel large deletions in the FBN1 gene in four patients of two unrelated families who met clinical diagnostic criteria for Marfan syndrome. One patient was found to have a FBN1 deletion encompassing exons 1-5. The other three patients had a 542 Kb deletion spanning the whole FBN1 gene and five additional genes (SLC24A5, MYEF2, CTXN2, SLC12A1, DUT) in the chromosome 15.Conclusions: Our findings expand the number of large FBN1 deletions, and emphasize the importance of screening for large genomic deletions in connective tissue disorders featuring aortopathies, especially for those with classic Marfan phenotype.

AB - Background: Connective tissue diseases characterized by aortic aneurysm, such as Marfan syndrome, Loeys-Dietz syndrome and Ehlers Danlos syndrome type IV are heterogeneous and despite overlapping phenotypes, the natural history, clinical manifestations and interventional course for each diagnosis can be quite unique. The majority of mutations involved in the etiology of these disorders are missense and nonsense mutations. However, large deletions and duplications undetected by sequencing may be implicated in their pathogenesis, and may explain the apparent lack of genotype-phenotype correlation in a subset of patients. The objective of this study was to search for large pathogenic deletions and/or duplications in the FBN1, TGFβR1, and TGFβR2 genes using multiplex-ligation dependent probe amplification (MLPA) in patients with aortopathy, in whom no mutations in the FBN1, TGFβR1, and TGFβR2 genes were identified by sequencing.Methods: The study included 14 patients from 11 unrelated families with aortic aneurysm. Of those, six patients (including 3 first-degree relatives), fulfilled the revised Ghent criteria for Marfan syndrome, and eight had predominantly aortic aneurysm/dilatation with variable skeletal and craniofacial involvement. MLPA for FBN1, TGFβR1, and TGFβR2 was carried out in all patients. A 385 K chromosome 15 specific array was used in two patients with a deletion of the entire FBN1 in order to define its size and boundaries.Results: We identified two novel large deletions in the FBN1 gene in four patients of two unrelated families who met clinical diagnostic criteria for Marfan syndrome. One patient was found to have a FBN1 deletion encompassing exons 1-5. The other three patients had a 542 Kb deletion spanning the whole FBN1 gene and five additional genes (SLC24A5, MYEF2, CTXN2, SLC12A1, DUT) in the chromosome 15.Conclusions: Our findings expand the number of large FBN1 deletions, and emphasize the importance of screening for large genomic deletions in connective tissue disorders featuring aortopathies, especially for those with classic Marfan phenotype.

UR - http://www.scopus.com/inward/record.url?scp=80053171792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053171792&partnerID=8YFLogxK

U2 - 10.1186/1471-2350-12-119

DO - 10.1186/1471-2350-12-119

M3 - Article

C2 - 21936929

AN - SCOPUS:80053171792

VL - 12

JO - BMC Medical Genetics

JF - BMC Medical Genetics

SN - 1471-2350

M1 - 119

ER -